HealthTech

Clinical Trials Success in Treatment of Prostate Enlargement (BPH), Chronic Prostatitis and Kidney Stones

Clinical Trials

Oxford, United Kingdom – April 5, 2023. Fine Treatment completed a new clinical that adds great help to people with chronic urological conditions, such as kidney stone disease, benign prostate enlargement (BPE and BPH) and chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). Fine Treatment, the manufacturer of Dr Allen’s therapeutic devices, supplies them to all people who want to treat these health problems without side effects and complications.

On the Fine Treatment website, you can read the scientific data on how Thermobalancing therapy with Dr Allen’s devices helps patients with enlarged prostates, chronic prostatitis, or kidney stones to reduce annoying symptoms. Also, everyone can read various medical articles about this unique therapy, like  “Innovative Thermobalancing therapy and Dr Allen’s Device for the first time employ body energy to treat chronic prostatic diseases effectively”, https://link.springer.com/article/10.1186/s40887-020-00035-0.

Patented Dr Allen’s Devices provide an excellent and easy-to-use at home treatment. Dr Allen’s Device has been registered with the British Medical Healthcare Agency since 2010 and has been tested for years. Used as a monotherapy, the device relieves the symptoms of an enlarged prostate or inflamed prostate and prevents health problems from current BPH or BPE medications and surgeries. Furthermore, Dr Allen’s Device dissolves kidney stones without renal colic.

Real costs of treating prostate problems and kidney stones

On average, the costs of treating BPH, chronic prostatitis and kidney stones highly common urological health conditions, are high.

For instance, the cost of extracorporeal shock wave lithotripsy (ESWL), which is the first line treatment for kidney stones, varies across different states in the United States and is about $10,000. An article, Costs variations for percutaneous nephrolithotomy (PCNL) in the U.S. from 2003-2015, identifies 2 groups of patients who have undergone PCNL, depending on the cost of the procedures: the low-cost group of $ 5,787 and a high-cost group of $ 38,590.

The average cost of medical treatment for BPH and chronic prostatitis per individual is $1536 per year, and BPH drugs are prescribed for life. The average cost of BPH surgeries can vary from $6,000 to $20,000 in the United States.

In contrast to hospital-based treatment options, the at-home treatment with Dr Allen’s Device is highly cost-effective. Priced at about USD200, this novel solution makes a positive difference not only to the users’ health but also to their budget.

Some valuable notes on standard treatments

The medical treatments commonly offered to people with BPH or BPH and chronic prostatitis do not actually treat the affected prostate but try to relieve the symptoms. All surgical interventions have side effects and subsequent negative impact on human health, which in turn can cause depression.

The Fine Treatment website provides the most reliable information on the treatment of chronic diseases: BPH, chronic prostatitis and urolithiasis, as well as up-to-date information on the results of new clinical trials.

Clinical Trials

 

 

 

 

 

About Fine Treatment:

Fine Treatment distributes Dr Allen’s therapeutic devices that offer unique, life-changing treatments for common chronic conditions. Totally risk-free, this treatment method is highly effective. The range of Dr Allen’s therapeutic devices is designed for the treatment of prostate conditions, BPH and chronic prostatitis; for dissolving kidney stones; treating lower back pain; easing upper spine stiffness and knee osteoarthritis; relieving chronic headaches and supporting brain function; for coronary heart disease, prevention and recovery after a heart attack.

Media Contact

Dr Simon Allen

Director of Fine Treatment https://finetreatment.com

Oxford, United Kingdom

Tel: +447958878300

e-mail: info@finetreatment.com

Comments
To Top

Pin It on Pinterest

Share This